Cite Filings / IRD / 0001104659-26-062694
Feed Companies Filings Check
Sign in
SCHEDULE 13G/A

Statement of Beneficial Ownership

Opus Genetics, Inc. · Filed 2026-05-15 · Acc 0001104659-26-062694

Documents 1

  • SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X02/primary_doc.xml

Around this filing

  • 2026-05-15 SCHEDULE 13G Statement of Beneficial Ownership
  • 2026-05-15 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2026-05-15 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2026-05-15 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2026-05-14 S-8 Securities Offered to Employees in Benefit Plans
  • 2026-05-13 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2026-05-13 SCHEDULE 13G Statement of Beneficial Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G/A · Caligan Partners LP 6.2%
  2. 2026-11-16 SCHEDULE 13G · Boxer Capital Management, LLC 5.4%
  3. 2026-11-16 SCHEDULE 13G · Cormorant Asset Management, LP 6.61%
  4. 2026-11-16 SCHEDULE 13G/A · BALYASNY ASSET MANAGEMENT L.P. 7.36%
Loading xslSCHEDULE_13G_X02/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…